Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sato, S.
Right arrow Articles by Kawakami, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sato, S.
Right arrow Articles by Kawakami, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2002, Vol. 11, No. 9 1045-1058
© 2002 Oxford University Press

Identification of transcriptional targets for Six5: implication for the pathogenesis of myotonic dystrophy type 1

Shigeru Sato1, Miwa Nakamura1, Diane H. Cho2, Stephen J. Tapscott2, Hidenori Ozaki1 and Kiyoshi Kawakami1,*

1Department of Biology, Jichi Medical School, Minamikawachi, Tochigi 329-0498, Japan and 2Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA

Myotonic dystrophy 1 (DM1) is the most common inherited neuromuscular disease in adults. The disorder, characterized by myotonia, muscle wasting and weakness, cataract, insulin resistance, and mental impairment, is caused by the expansion of an unstable CTG repeat located in the 3' untranslated region of DMPK. The repeat expansion suppresses the expression of the homeobox gene SIX5. We describe here an experimental system to identify downstream transcriptional targets of mouse Six5 in order to elucidate the role of SIX5 in the pathogenesis of DM1 and development. By overexpressing a constitutively active Six5 (VP16–Six5wt) using adenovirus-mediated gene transfer in P19 cells and subsequent expression profiling using cDNA arrays, 21 genes, whose expression level increased by the treatment, were identified as potential target genes. Genes expressed in the somites, skeletal muscles, brain and meninges comprised the majority, suggesting the role of Six5 in the development and function of mesodermal tissues and brain. We provide evidence that Igfbp5 encoding a component of IGF signaling is a direct Six5-target. Moreover, the overall expression level of Igfbp5 was decreased in Six5-deficient mouse fibroblasts, and the response of human IGFBP5 to MyoD-induced muscle conversion was altered in cells of DM1 patients. Our results not only identify Six5 as an activator that directs Igfbp5 expression but also suggest that reduced SIX5 expression in DM1 might contribute to specific aspects of the DM1 phenotype.

* To whom correspondence should be addressed. Tel: +81 285 58 7311; Fax: +81 285 44 5476; Email: kkawakam{at}jichi.ac.jp


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
DevelopmentHome page
E. Kutejova, B. Engist, M. Self, G. Oliver, P. Kirilenko, and N. Bobola
Six2 functions redundantly immediately downstream of Hoxa2
Development, April 15, 2008; 135(8): 1463 - 1470.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Grinchuk, Z. Kozmik, X. Wu, and S. Tomarev
The Optimedin Gene Is a Downstream Target of Pax6
J. Biol. Chem., October 21, 2005; 280(42): 35228 - 35237.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
L. Smith and A. Greenfield
DNA microarrays and development
Hum. Mol. Genet., April 2, 2003; 12(90001): R1 - 8.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. Ikeda, Y. Watanabe, H. Ohto, and K. Kawakami
Molecular Interaction and Synergistic Activation of a Promoter by Six, Eya, and Dach Proteins Mediated through CREB Binding Protein
Mol. Cell. Biol., October 1, 2002; 22(19): 6759 - 6766.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.